As of 2026-03-14, the EV/EBITDA ratio of Cue Biopharma Inc (CUE) is -0.33. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CUE's latest enterprise value is 12.29 mil USD. CUE's TTM EBITDA according to its financial statements is -37.73 mil USD. Dividing these 2 quantities gives us the above CUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 17.2x | 14.7x |
| Forward P/E multiples | 18.4x - 22.2x | 20.5x |
| Fair Price | (8.69) - (8.12) | (8.31) |
| Upside | -3162.7% - -2963.4% | -3027.6% |
| Date | EV/EBITDA |